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ABSTRACT Human p32 (also known as SF2-associated
p32, p32yTAP, and gC1qR) is a conserved eukaryotic protein
that localizes predominantly in the mitochondrial matrix. It is
thought to be involved in mitochondrial oxidative phosphor-
ylation and in nucleus–mitochondrion interactions. We report
the crystal structure of p32 determined at 2.25 Å resolution.
The structure reveals that p32 adopts a novel fold with seven
consecutive antiparallel b-strands f lanked by one N-terminal
and two C-terminal a-helices. Three monomers form a dough-
nut-shaped quaternary structure with an unusually asymmet-
ric charge distribution on the surface. The implications of the
structure on previously proposed functions of p32 are dis-
cussed and new specific functional properties are suggested.
Human p32 was originally isolated by copurification with the
nuclear pre-mRNA splicing factor SF2yASF, with which it
appeared to be associated, although no evidence of a splicing
function was obtained (1). Since the original study, it has
become apparent that p32 is an evolutionarily conserved
eukaryotic protein. Homologous genes have been identified in
a number of eukaryotic species, ranging from fungi to mam-
mals, as a result of both biochemical studies and genome
sequencing efforts. In addition to its ability to bind to the
splicing factor SF2yASF in vitro, many additional properties or
apparent functions of p32 have been reported. It can interact
with many viral proteins, including HIV-1 Tat (2–4) and Rev
(5, 6), EBNA-1 of Epstein–Barr virus (7), ORF P of herpes
simplex virus (8), and core protein V of adenovirus (9). It has
also been reported that p32 interacts with the globular head
domain of the plasma complement component C1q, whose
hemolytic activity is inhibited as a result (10). Binding of p32
to transcription factor IIB (11), the lamin B receptor (12), high
molecular-weight kininogen and factor XII (13), vitronectin
(14), and hyaluronic acid (15) has also been reported.
Unexpectedly, immunofluorescence and subcellular frac-
tionation studies have shown that p32 and its yeast homologue
localize predominantly in the mitochondrial matrix (9, 16–18).
We have confirmed these findings in HeLa cells using multiple
anti-p32 monoclonal antibodies, both by immunoblotting of
subcellular fractions and by indirect immunofluorescence (I.
Watakabe and A.R.K., unpublished results). It is puzzling how
p32, a mitochondrial protein, can participate in the aforemen-
tioned processes, which take place at various nonmitochon-
drial locations. There is some evidence that a small fraction of
p32 protein localizes in the nucleus (9). Furthermore, the
distribution of p32 appears to be altered during adenovirus
infection, with p32 migrating to the nucleus together with a
viral core protein (9). These observations suggested that p32
plays a bridging role in nucleus–mitochondrion interactions.
p32 has been shown to be important for the maintenance of
mitochondrial oxidative phosphorylation (16). However, the
exact physiological role of p32 in mitochondria remains un-
known. In an effort to understand the structure and function
of p32, we have crystallized and determined the structure of
the human protein at 2.25 Å resolution. To our knowledge, the
structure is the first to be solved among this class of proteins,
and it has a new fold.
MATERIALS AND METHODS
Protein Purification and Crystallization. Recombinant p32
protein (aa 74–282, with Leu74 to Met74 substitution) was
produced in Escherichia coli as described (1). p32 was purified
by a 65% to 90% ammonium sulfate cut, followed by chro-
matography on Mono Q (Amersham Pharmacia). Peak p32
fractions eluted from the Mono Q column [3–5 mgyml, in 20
mM Hepes (pH7.5)y5% glyceroly0.6M NaCly1 mM EDTAy1
mM EGTAy0.1% b-mercaptoethanol] were readily crystal-
lized in buffers containing acetate. The best diffracting crystals
were grown by hanging-drop vapor diffusion at 16°C by using
a well solution containing 10% glycerol, 25% 2-methyl-2,4-
pentanediol, and 5–10 mM sodium acetate (pH 4.6). The
optimal protein concentration used was approximately 3 mgy
ml. After mixing equal volumes of protein solution and well
solution, crystals began to form between a few minutes to a few
days, depending on the acetate concentration. p32 crystallized
in spacegroup P21 with cell dimensions of a 5 58.63 Å, b 5
56.48 Å, c 5 93.83 Å, and b 5 96°. There are three p32
molecules per asymmetric unit. Crystals used for x-ray diffrac-
tion had typical dimensions of 0.1 3 0.1 3 0.3 mm3.
Selenomethionine (SeMet)-substituted p32 was produced in
the methionine auxotroph DL41(DE3) in a defined medium
that supplies SeMet (19). Purification and crystallization of
SeMet p32 was carried out as outlined for the native protein.
Data Collection and Structure Determination. A complete
2.45-Å resolution native diffraction data set was collected at
beamline X26C at the National Synchrotron Light Source
(NSLS), Brookhaven National Laboratory, by using an MAR
(MAR Research, Hamburg) imaging plate detector. We at-
tempted to solve the structure by the multiple isomorphous
replacement method, but an extensive search for heavy-atom
derivatives was not successful. We then turned to the multi-
wavelength anomalous diffraction (MAD) method using Se-
Met as anomalous scatterers. MAD data were collected at
beamline X12C by using a single-cell Brandeis charge-coupled
device detector at NSLS. Four data sets at wavelengths l0 5
1.00 Å, l1 5 0.9789 Å, l2 5 0.9786 Å, and l3 5 0.95 Å were
collected from a single crystal at 100 K. All raw diffraction data
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were processed by using the HKL software package (20). Data
processing statistics are shown in Table 1.
Determination of selenium atom positions, refinement of
the selenium atom parameters, and phase calculation were all
carried out by using the SOLVE (21) and PHASES (22) software
packages. The quality of the electron density from MAD
phasing is excellent (Fig. 1). Solvent flattening and noncrys-
tallographic symmetry averaging were not necessary for chain
tracing and amino acid assignments. Almost all of the amino
acids present in the refined model were placed into the MAD
electron density by using the graphics program O (23).
The structure was refined by using X-PLOR and CNS (24). An
initial round of X-PLOR refinement brought the R-factor from
48.7 to 27.2%, by using the data in the resolution range of
8.0–3.0 Å. Extension to higher resolution and inclusion of
low-resolution data with bulk solvent correction were carried
out by using CNS. The stereochemistry of the refined model was
assessed by the PROCHECK program (25).
The programs CATH (26), DALI (27), and SCOP (28) were used
to search for structural and folding similarities against the
Protein Data Bank (29) protein structure database. MOLSCRIPT
(30), RASTER3D (31), and GRASP (32) programs were used to
generate figures.
RESULTS
We have crystallized and solved the crystal structure of human
p32 to 2.25 Å resolution. The electron density map (Fig. 1)
produced from SeMet MAD phasing allows unambiguous
Ca-chain tracing and side-chain assignments, except for two
disordered segments in each molecule within the asymmetric
unit. The crystallized protein corresponds to the mature form
of p32 (Fig. 2A), which lacks a 73-residue signal sequence at the
N terminus. The signal sequence is necessary to target the
protein to mitochondria (9, 16–18). The structure has been
refined to 2.25 Å resolution with a crystallographic R-factor of
17.3% (Rfree 5 23.4%). The refined model has excellent
stereochemistry. The Ramachandran plot shows 90.2% of the
nonglycine nonproline residues within the most favored region
and 9.0% in the additional allowed regions.
Structure Description. There are three p32 molecules in an
asymmetric unit, and they form a tightly bound trimer (Fig. 2B)
with a noncrystallographic three-fold symmetry relating the
monomers. This oligomeric state is most likely physiological,
because it is consistent with solution data obtained by gel-
filtration chromatography (18) and by laser-scattering molec-
ular sizing (unpublished data). The doughnut-shaped trimer
has an outer diameter of approximately 75 Å, an average inner
diameter of approximately 20 Å, and a thickness of approxi-
mately 30 Å.
All three subunits have very similar conformations, despite
our deliberate effort not to enforce the noncrystallographic
symmetry during the process of model building and refine-
ment. The pair-wise rms deviations of Ca positions were 0.89
Å, 0.84 Å, and 0.60 Å, respectively, between subunits A and B,
A and C, and B and C. Monomeric p32 does not have any
obviously distinct domains. Each monomer consists of seven
consecutive b-strands, designated b1 through b7 (Fig. 3A),
which form a highly twisted antiparallel b-sheet, with b1 nearly
perpendicular to b7. The b-strands are flanked by one N-
terminal (aA) and two C-terminal (aB and aC) a-helices. The
topological arrangement of secondary structure elements is
shown schematically in Fig. 3B. All three a-helices are located
on the same side of the b-sheet. Helix aB lies parallel to the
b-sheet, with the helix axis perpendicular to the direction of
individual strands. Helix aB and the N-terminal portion (four
turns) of helix aC make extensive hydrophobic contacts with
the b-sheet, which appear to be essential for the stability of the
structure. The N-terminal helix aA does not contact the
b-sheet within the same monomer, but forms an antiparallel
coiled-coil with the C-terminal portion (five turns) of aC. This
coiled-coil region is important for protein–protein interactions
responsible for homooligomerization. Despite its simplicity,
FIG. 1. MAD-phased electron density map. A portion of the
MAD-phased electron density covering the central b-strands is shown
with a refined model superimposed onto the map. The electron density
was computed to 2.5 Å resolution and contoured at 1.2 s level.
Table 1. Statistics from the crystallographic analysis
Measurement Values
Diffraction data l0 l1 l2 l3
Resolution, Å 2.38 2.38 2.38 2.25
Observed reflections 143,315 145,771 152,031 170,171
Unique reflections 22,536 22,989 24.077 27,284
Completeness, % 90.7 92.0 89.1 92.6
Average Iys 13.9 12.8 13.3 15.4
Rmerge, %* 3.5 4.1 5.2 4.5
Phasing
Se sites 9
Phasing power† at 2.5 Å
Isomorphous 2.65 — 1.53 3.24
Anomalous — 1.78 3.65 2.25
Overall figure of merit 0.67
Refinement
Resolution range, Å `22.25
R-factor,‡ Rfree, % 17.3 23.4
Reflections with uFu . 2s 26,812
Number of protein atoms 4,259
Number of water molecules 340
Average B-factor, Å2 34.2
Rms deviations
Bond lengths, Å 0.007
Bond angles, ° 1.18
Dihedrals, ° 21.8
Improper, ° 0.64
*Rmerge 5 SuI 2 ^I&uyS^I&, where I is the measured intensity and ^I&
is the averaged intensity of multiple measurements of the same
reflection. The summation is over all the observed unique reflections.
†Phasing power 5 rms (^FH&yE), where FH is the calculated structure
factor of the heavy atoms and E is the residual lack of closure.
‡R-factor 5 SiFou 2 uFcuuySuFou, where Fo denotes the observed
structure factor amplitude and Fc denotes the structure factor
calculated from the model.
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the p32 structure does not belong to any known protein fold.
A search for structure similarity against folding and structure
databases did not produce any significant matches.
The Trimer. Three p32 molecules form a doughnut-shaped
quaternary structure. The channel has a diameter of about 20
Å, but the loops connecting b6 and b7 partially cover the
channel (Fig. 2B), reducing the diameter of the opening to
about 10 Å. The channel wall is formed by the b-sheets from
all three subunits. However, this all-b wall is distinct from
other all-b structures (33), such as up-and-down b-barrels, in
that the b-sheets from all three p32 monomers are highly
twisted and can form only a hyperboloid surface rather than a
cylindrical wall as in b-barrels. Because of the high degree of
twisting, b-strands from adjacent monomers do not form
contiguous b-sheets. Instead, residues located at the tip of
b1-turn-b2 and the loop connecting b3 and b4 interact with b7
of the adjacent molecule (Fig. 4). In particular, the main chain
A
B
FIG. 2. Overall structure of p32. (A) Structure-based alignment of
p32 sequences from human (PID g338043), mouse (PID g743485),
Caenorhabditis elegans (PID g3334445) and S. cerevisiae (PID
g557799). Only the sequences corresponding to the mature human
protein are shown. Positions with four identical amino acids are shown
in red letters over yellow background; positions with four similar
amino acids are shown in plain red letters; positions with three
identities are shown in green letters. Related expressed sequence tag
fragments or genomic sequences can also be found in Drosophila (NID
g3112239), zebrafish (NID g2446858), and Arabidopsis (PID
g3334441). PID and NID are protein and nucleotide identification
numbers in GenBank. (B) Ribbon representation of the p32 trimer,
looking down the noncrystallographic three-fold axis. The dotted lines
show disordered segments in the structure. The three monomers that
make up the trimer are colored red, green and cyan, and are referred




FIG. 3. Folding topology of p32. (A) Ribbon representation of a
p32 monomer. The secondary structure elements are labeled. (B)
Schematic drawing of the p32 topology.
FIG. 4. Subunit interface between p32 monomers. The interactions
between monomers B (green) and C (cyan) within the p32 trimer are
shown, as viewed from the inside of the channel. The portions of the
two loops in subunit C and one loop in subunit B that interact with
each other (see text) are indicated in yellow. In addition, extensive
intermolecular interactions involve contacts between aC and aA of
monomer C with the b-sheet and aB of monomer B, respectively, as
described in the text.
3574 Biochemistry: Jiang et al. Proc. Natl. Acad. Sci. USA 96 (1999)
carbonyl of Asn-114 and the amide group of Thr-116 form
intermolecular hydrogen bonds to Og and the carbonyl group
of Thr-222, respectively; the side chain atoms of Asn-134 and
Asn-136 are involved in several intermolecular hydrogen
bonds with main chain atoms of Asp-221, Asn-223, and
Thr-225.
The coiled-coil region of aA and aC forms extensive
intermolecular contacts: aA packs with the antiparallel aB of
an adjacent monomer, and the C-terminal region of aC packs
against the back of the b-sheet (Fig. 4). Most of these
interactions are hydrophobic in nature, except for the inter-
molecular electrostatic pairing of Arg-246 and Asp-79. Asp-79
is not a conserved residue, but Arg-246 is invariant and is
located in a region surrounded by several other invariant
residues (see below). In summary, the overall architecture of
the trimer can be visualized as if the b-sheets form a hyper-
boloid-shaped spool with the a-helices wrapping around it.
Surface Characteristics. p32 is a very acidic protein, with a
calculated pI of 4. However, the charge distribution on the
protein surface is highly asymmetric (Fig. 5 A–C). Both the side
of the doughnut that includes the loops connecting b3 to b4
and b5 to b6 and the inside of the channel have a high
concentration of negatively charged residues (Fig. 5A). Both
loops contain disordered segments, which have a combined net
charge of 212 units. In contrast, the opposite side of the
doughnut is much less negatively charged (Fig. 5B). This
polarity in charge distribution clearly suggests asymmetric
functional roles for the two sides of the protein.
Sequence comparisons among homologous proteins from
different species show that the region spanning aB and aC is
highly conserved. This conservation suggests that oligomer-
ization is an inherent feature of this class of proteins. In
addition, several conserved residues scattered throughout the
p32 sequence cluster together in space, forming conserved
regions on the protein surface (Fig. 5 D–F). These conserved
surface features are very likely to be important for protein–
protein interactions and ligand binding. Two regions of con-
servation stand out: first, five residues, Glu-89, Leu-231,
Asp-232, Glu-264, and Tyr-268, form a shallow pocket on the
negatively charged side of the doughnut (Fig. 5E); second, four
residues, Arg-122, Lys-123, Arg-246, and Gly-247, are distrib-
uted closely together around the outer perimeter (Fig. 5F). In
contrast, only one invariant residue, Glu-117, is located inside
the channel. With the knowledge of the p32 three-dimensional
structure, rational mutations of these conserved residues
should help to test the proposed functions of the protein.
DISCUSSION
We solved the three-dimensional structure of human p32 in the
hope of revealing structural similarities with other proteins of
known functions, which would thus shed light on the functions
A B C
D E F
FIG. 5. Surface distribution of charged and phylogenetically conserved amino acids. (A) Charge distribution on the protein surface, viewed from
the same direction as in Fig. 1B. This side is referred to as the positive side. Positively and negatively charged electric potential are indicated in
blue and red, respectively. The surface was calculated by using a probe radius of 1.4 Å, and the potential is displayed at the scale of 220 kBT to
120 kBT, where kB is the Boltzmann constant. (B) A significantly higher number of negatively charged residues is present on the opposite side of
the protein surface. This side is referred to as the negative side. (C) A side view of the protein surface shows the asymmetry of charge distribution
on the two sides of the protein surface. (D) Distribution of conserved amino acids on the positive side of the protein surface. Magenta indicates
identical residues, and cyan indicates similar residues. They are shown in Fig. 2 A as red letters over yellow background and plain red letters,
respectively. (E) Several conserved and spatially clustered residues form a shallow pocket on the negative side of the protein surface. (F) Distribution
of conserved amino acids on the outer perimeter of the protein surface.
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of p32. However, the structure of p32 as reported here turned
out to have an entirely new fold. In retrospect, it is perhaps not
surprising that a protein with unusual properties has an
unusual structure. To date, nearly 8,000 protein structures
have been solved (29), which fall into approximately 600
different types of fold (26). As additional structures are solved,
the total number of topological folds is expected to increase
somewhat, but already most new structures tend to fall into
known topological families. Therefore, each new fold provides
a valuable prototype for understanding the architecture, fold-
ing, and evolution of proteins.
Although the structure of p32 did not reveal structural
similarities to other proteins or motifs, this study provides
valuable information for understanding and dissecting the
functions of p32 and related proteins in the future. First, the
structure revealed that oligomerization is an inherent feature
of this class of proteins. Second, the conservation of specific
amino acids clustered at discrete locations on the p32 trimer
surface points to the likely functional importance of these
regions. Third, the unusual asymmetric charge distribution
suggests distinct functions for the two sides of the trimeric
protein complex.
Many diverse functions have been proposed for p32, often
involving very different subcellular locations, and it is highly
unlikely that p32 can fulfill all these roles in a physiological
setting. Many of the links to these functions were originally
proposed on the basis of physical interactions of p32 with other
molecules, often using two-hybrid or pull-down strategies, and
these techniques have also been used to map smaller regions
of p32 that mediate the observed interactions. However, in the
absence of structural information, this type of deletion analysis
could not take into account the structural integrity of the
protein, including the folding of monomers and the stability of
the trimer.
Concerning the normal cellular functions of p32, a recent
study reported that disruption of the p32 homologous gene in
Saccharomyces cerevisiae slowed down growth in glycerol me-
dium but not in glucose medium, suggesting that p32 is
involved in mitochondrial oxidative phosphorylation (16). In
another report, the yeast p32 homologue was found to interact
with the sorting signal of cytochrome b2 in vitro (18). Accord-
ing to this study, gene disruption did not appear to affect the
sorting of cytochrome b2, nor did it affect cell growth in media
with either fermentable or nonfermentable carbon sources.
Further studies will be necessary to reconcile these discrep-
ancies and to understand the mitochondrial functions of p32.
In the meantime, the crystal structure already suggests some
interesting clues for further functional studies of p32.
One interesting possibility is that p32 may serve as a
high-capacity divalent cation storage protein to modulate
mitochondrial matrix cation concentration, because 23% (48
amino acids) of its residues are aspartic and glutamic acids, and
they are distributed on the surface of the trimer. This acidic
surface characteristic is somewhat reminiscent of calseques-
trin, a major Ca21 storage protein found in the interior of
sarcoplasmic reticulum vesicles (34). Calsequestrin is also rich
in aspartic and glutamic acids (about 30% Asp and Glu, and
a pI value around 4) and can bind and release 40–50 Ca21 ions
per molecule in each muscle contraction–relaxation cycle.
Modulation of intracellular Ca21 concentration by such pro-
teins may directly affect the rate of pumping of Ca21 into
sarcoplasmic reticulum vesicles. Despite the structural differ-
ences between calsequestrin (35) and p32, the two proteins
may act similarly in modulating Ca21 ion levels, with the latter
doing so in the mitochondrial matrix. Mitochondrial Ca21 ion
levels are strongly coupled with oxidative metabolism (36). For
example, the activities of several mitochondrial dehydroge-
nases, such as pyruvate dehydrogenase, NAD-isocitrate dehy-
drogenase, and oxoglutarate dehydrogenase, are directly or
indirectly regulated by intramitochondrial Ca21 levels (37). We
speculate that p32 may regulate mitochondrial oxidative phos-
phorylation by modulating the concentrations of divalent
cations such as Ca21.
An interesting feature of p32 is its high negative-charge
density and asymmetric charge distribution, which suggest a
possible mode of association with the inner mitochondrial
membrane. The negatively charged side of p32 may potentially
bind to the inner mitochondrial membrane in the presence of
divalent metal ions, as negatively charged phospholipids can
chelate divalent cations. Indeed, circumstantial evidence sug-
gests that p32 is capable of associating with membranes (10, 13,
14, 18). If p32 is indeed localized proximally to the inner
mitochondrial membrane, the central channel in the p32 trimer
may have important functions. The channel is large enough to
allow passage of a particle of moderate size. Depending on the
degree of blockage by the loops connecting b6 and b7, which
may undergo conformational changes, the opening would have
a diameter ranging from 10 to 20 Å. This channel size would
correspond to a range of molecular mass cutoffs for globular
molecules of about 0.4–3 kDa, assuming an average density of
about 1.35 gycm3 (average protein density). The inner mito-
chondrial membrane has various types of pores of this size for
protein import and exchange of solute molecules. Protein
import into mitochondria has been extensively studied in
recent years, and a number of trans-membrane proteins
(TIMs) have been shown to be involved in protein import
through the inner membrane (38). However, there is so far no
evidence of the involvement of p32 in mitochondrial protein
import or of its interaction with TIMs, except that p32 can
interact with the sorting signal of cytochrome b2 in vitro (18).
Interestingly, in addition to the protein import channel, the
mitochondrial inner membrane has a large conductance chan-
nel, known as the permeability transition pore (PTP) (39). The
PTP allows free diffusion of solute molecules with a molecular
mass of up to 1.5 kDa when the pore is fully open. Further-
more, high Ca21 concentration appears to promote pore
opening. This process plays an important role in triggering
programmed cell death (40, 41). An intriguing speculation is
that p32 may participate in apoptosis by interacting with the
matrix side of the integral membrane component of PTP and
regulating the pore opening in a divalent-metal concentration-
dependent manner.
Curiously, most of the reported interactions of p32 should
take place outside of mitochondria. For p32 to interact with the
globular head domain of C1q (10), H-kininogen (13), vitro-
nectin (14), and hyaluronic acid (15), it should be located on
the extracellular side of the plasma membrane or in the
extracellular matrix. Although p32 has been detected in the
supernatants of several cultured cells and in normal human
and rat sera (42), there is no direct evidence that it is
specifically targeted to the cell surface or secreted. Small
amounts of cell surface or plasma p32 may actually originate
from lysed cells. An interesting question is whether the exter-
nalization of p32 is the result of an apoptotic process, as we
have speculated above that p32 might be involved in apoptosis.
p32 is capable of interactions with numerous viral proteins,
and many of these reported interactions take place in the
nucleus. It is now clear that p32 is mainly localized in mito-
chondria at steady state and under normal circumstances.
However, localization of a small fraction of p32 in the nucleus
andyor dynamic shuttling of p32 between mitochondria and
the nucleus remain possible. In fact, some nuclear localization
has been reported by using different fixation procedures or
different cell lines (9). More strikingly, it was observed that the
localization of p32 in HeLa cells is altered during adenovirus
infection (9). This finding led to the suggestion that p32 might
be a part of a continuous nucleus–mitochondrion network that
allows shuttling of macromolecules, and that adenovirus might
take advantage of this host process to deliver its genome to the
nucleus (9). The validity of this hypothesis remains to be tested.
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In summary, we have reported the crystal structure of
human p32 at 2.25 Å resolution. The crystal structure revealed
that p32 has a novel fold. Three p32 molecules form a
doughnut-shaped quaternary structure, with a sizable central
channel and an unusual asymmetric charge distribution on the
surface. Based on the structure, we have proposed several
possible roles that p32 might play inside mitochondria. These
and other proposals for the function of p32 and related
proteins can now be further studied with the benefit of a
detailed structure of the p32 trimer.
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